Advantage Alpha Capital Partners LP Vericel Corp Transaction History
Advantage Alpha Capital Partners LP
- $515 Million
- Q1 2024
A detailed history of Advantage Alpha Capital Partners LP transactions in Vericel Corp stock. As of the latest transaction made, Advantage Alpha Capital Partners LP holds 24,988 shares of VCEL stock, worth $1.13 Million. This represents 0.25% of its overall portfolio holdings.
Number of Shares
24,988
Previous 33,876
26.24%
Holding current value
$1.13 Million
Previous $1.21 Million
7.71%
% of portfolio
0.25%
Previous 0.23%
Shares
2 transactions
Others Institutions Holding VCEL
# of Institutions
263Shares Held
48.9MCall Options Held
150KPut Options Held
128K-
Black Rock Inc. New York, NY7.97MShares$359 Million0.01% of portfolio
-
Brown Capital Management LLC Baltimore, MD4.95MShares$223 Million4.62% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.41MShares$154 Million0.0% of portfolio
-
State Street Corp Boston, MA3.21MShares$145 Million0.01% of portfolio
-
Conestoga Capital Advisors, LLC2.33MShares$105 Million1.77% of portfolio
About Vericel Corp
- Ticker VCEL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 47,178,000
- Market Cap $2.13B
- Description
- Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...